Rectal Adenocarcinoma
Showing NaN - NaN of 5
Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,
Active, not recruiting
- Colon Adenocarcinoma
- +18 more
- Cetuximab
- +5 more
-
Anchorage, Alaska
- +797 more
Jan 9, 2023
Improve Organ Preserving Strategies in Rectal Cancer
Recruiting
- Rectal Adenocarcinoma
- +8 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 30, 2022
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States
Active, not recruiting
- Rectal Adenocarcinoma
- +2 more
- Capecitabine
- +6 more
-
Birmingham, Alabama
- +649 more
Aug 5, 2022
Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)
Active, not recruiting
- Rectal Adenocarcinoma
- LY2157299
- +3 more
-
Portland, OregonProvidence Cancer Center
Mar 22, 2022
Immunoscore in Rectal Cancer
Completed
- Cancer of the Rectum
- +4 more
- Diagnostic Biopsy and Surgical Procedure
- +3 more
-
Portland, Oregon
- +1 more
Aug 27, 2018